Shao X - Search Results

1

Phase separation-based screening identifies arsenic trioxide as the N-Myc-DNA interaction inhibitor for neuroblastoma therapy.

Xu A, Huang Y, Wu B, Zhang J, Deng B, Cai M, Cao J, Wang J, Yang B, Shao X, He Q, Ying M. Xu A, et al. Among authors: shao x. Cancer Lett. 2025 Jan 11;612:217449. doi: 10.1016/j.canlet.2025.217449. Online ahead of print. Cancer Lett. 2025. PMID: 39805390 No abstract available.

2

All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages.

Zhou Q, Xian M, Xiang S, Xiang D, Shao X, Wang J, Cao J, Yang X, Yang B, Ying M, He Q. Zhou Q, et al. Among authors: shao x. Cancer Immunol Res. 2017 Jul;5(7):547-559. doi: 10.1158/2326-6066.CIR-16-0259. Epub 2017 May 17. Cancer Immunol Res. 2017. PMID: 28515123

3

Bortezomib sensitizes human osteosarcoma cells to adriamycin-induced apoptosis through ROS-dependent activation of p-eIF2α/ATF4/CHOP axis.

Xian M, Cao H, Cao J, Shao X, Zhu D, Zhang N, Huang P, Li W, Yang B, Ying M, He Q. Xian M, et al. Among authors: shao x. Int J Cancer. 2017 Sep 1;141(5):1029-1041. doi: 10.1002/ijc.30792. Epub 2017 May 31. Int J Cancer. 2017. PMID: 28524233

4

Protein phase separation: A novel therapy for cancer?

Wang W, Chen Y, Xu A, Cai M, Cao J, Zhu H, Yang B, Shao X, Ying M, He Q. Wang W, et al. Among authors: shao x. Br J Pharmacol. 2020 Nov;177(22):5008-5030. doi: 10.1111/bph.15242. Epub 2020 Sep 28. Br J Pharmacol. 2020. PMID: 32851637 Free PMC article. Review.

5

Deneddylation of PML/RARα reconstructs functional PML nuclear bodies via orchestrating phase separation to eradicate APL.

Shao X, Chen Y, Xu A, Xiang D, Wang W, Du W, Huang Y, Zhang X, Cai M, Xia Z, Wang Y, Cao J, Zhang Y, Yang B, He Q, Ying M. Shao X, et al. Cell Death Differ. 2022 Aug;29(8):1654-1668. doi: 10.1038/s41418-022-00955-8. Epub 2022 Feb 22. Cell Death Differ. 2022. PMID: 35194189 Free PMC article.

6

The HER2 inhibitor TAK165 Sensitizes Human Acute Myeloid Leukemia Cells to Retinoic Acid-Induced Myeloid Differentiation by activating MEK/ERK mediated RARα/STAT1 axis.

Shao X, Liu Y, Li Y, Xian M, Zhou Q, Yang B, Ying M, He Q. Shao X, et al. Sci Rep. 2016 Apr 14;6:24589. doi: 10.1038/srep24589. Sci Rep. 2016. PMID: 27074819 Free PMC article.

7

2-Bromopalmitate sensitizes osteosarcoma cells to adriamycin-induced apoptosis via the modulation of CHOP.

Xu T, Huang C, Qi XT, Yang XC, Zhang N, Cao J, Wang C, Zhu H, Yang B, He QJ, Shao XJ, Ying MD. Xu T, et al. Eur J Pharmacol. 2019 Feb 5;844:204-215. doi: 10.1016/j.ejphar.2018.12.019. Epub 2018 Dec 12. Eur J Pharmacol. 2019. PMID: 30552901

8

Inhibition of M2-like macrophages by all-trans retinoic acid prevents cancer initiation and stemness in osteosarcoma cells.

Shao XJ, Xiang SF, Chen YQ, Zhang N, Cao J, Zhu H, Yang B, Zhou Q, Ying MD, He QJ. Shao XJ, et al. Acta Pharmacol Sin. 2019 Oct;40(10):1343-1350. doi: 10.1038/s41401-019-0262-4. Epub 2019 Jul 11. Acta Pharmacol Sin. 2019. PMID: 31296953 Free PMC article.

9

Advances in differentiation therapy for osteosarcoma.

Chen Y, Cao J, Zhang N, Yang B, He Q, Shao X, Ying M. Chen Y, et al. Among authors: shao x. Drug Discov Today. 2020 Mar;25(3):497-504. doi: 10.1016/j.drudis.2019.08.010. Epub 2019 Sep 6. Drug Discov Today. 2020. PMID: 31499188 Review.

10

Post-translational modification of retinoic acid receptor alpha and its roles in tumor cell differentiation.

Xu A, Zhang N, Cao J, Zhu H, Yang B, He Q, Shao X, Ying M. Xu A, et al. Among authors: shao x. Biochem Pharmacol. 2020 Jan;171:113696. doi: 10.1016/j.bcp.2019.113696. Epub 2019 Nov 11. Biochem Pharmacol. 2020. PMID: 31726045 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,792 results

Search Page

Filters